Qureos
Evox T

Evox T

Domain / Industry not specified
LocationUnited States
Company SizeN/A

About Company

Evox Therapeutics Ltd. is an innovative biotechnology company focused on developing next-generation genetic medicines for severe neurodegenerative diseases. Founded in 2016 from scientific foundations at the University of Oxford and Karolinska Institute, Evox is working to expand the reach of genetic medicine into the brain and address the underlying causes of disease. The company’s proprietary ExoEdit® platform combines the natural delivery capabilities of exosomes with advanced CRISPR-based genome-editing technology. This approach is designed to enable targeted delivery of genetic medicines to the central nervous system and other tissues that can be difficult to reach with conventional delivery technologies.

© 2026 Qureos. All rights reserved.